Pyrexia, or fever, is a common symptom in clinical practice, often indicative of an underlying inflammatory process, infection, or disease. Understanding its etiology, clinical presentation, and management strategies is essential for effective patient care.
Fever is a complex physiological response to a variety of stimuli, most commonly infection. Pyrogens, substances that induce fever, can be exogenous (like bacterial toxins) or endogenous (like cytokines). These pyrogens trigger the hypothalamus to elevate the body's set point temperature, leading to fever.
Patients with pyrexia often present with elevated body temperature, chills, sweating, and malaise. Depending on the underlying cause, additional symptoms may include headache, myalgia, and other system-specific signs. A thorough patient history and physical examination are vital in determining the cause of the fever.
Management of pyrexia primarily involves treating the underlying cause. Symptomatic treatment with antipyretics can be used to alleviate discomfort. However, it is important to note that fever is a beneficial response, enhancing immune function and inhibiting growth of pathogens. Therefore, unless distressing to the patient, it may not always require treatment.
Diagnostic tests play a crucial role in identifying the cause of the fever. These may include complete blood count, blood cultures, imaging studies, and specific tests based on clinical suspicion. Timely and appropriate diagnostic evaluation can guide effective treatment strategies.
Pyrexia is a common clinical symptom with diverse etiology. A comprehensive understanding of its pathophysiology, clinical presentation, and management strategies is essential for effective patient care. By adopting a systematic approach, healthcare professionals can ensure accurate diagnosis and effective treatment of the underlying cause of the fever.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation